Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages

被引：2
|
作者：
Wang, Qian [1 ]
Guo, Yicheng [1 ]
Ho, Jerren [1 ]
Ho, David D. [1 ]
机构：
[1] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 19期
关键词：
D O I：
10.1056/NEJMc2410203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1863 / 1864
页数：2
相关论文
共 50 条
  • [11] Emergence of SARS-CoV-2 Omicron sub-lineage JN.1 in Bangladesh
    Jony, Manjur Hossain Khan
    Alam, Ahmed Nawsher
    Nasif, Md. Abdullah Omar
    Sultana, Sharmin
    Anwar, Rubaid
    Rudra, Mithun
    Rahman, Mahbubur
    Rahman, Mustafizur
    Qadri, Firdausi
    Shirin, Tahmina
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2024, 13 (06):
  • [12] Antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against SARS-CoV-2 omicron subvariants including JN.1, KP.3.1.1, and XEC
    Uriu, Keiya
    Kaku, Yu
    Uwamino, Yoshifumi
    Fujiwara, Hiroshi
    Saito, Fumitake
    Sato, Kei
    LANCET INFECTIOUS DISEASES, 2025, 25 (02): : e61 - e61
  • [13] Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion
    Zhang, Lu
    Dopfer-Jablonka, Alexandra
    Cossmann, Anne
    Stankov, Metodi, V
    Graichen, Luise
    Moldenhauer, Anna-Sophie
    Fichter, Christina
    Aggarwal, Anupriya
    Turville, Stuart G.
    Behrens, Georg M. N.
    Pohlmann, Stefan
    Hoffmann, Markus
    ISCIENCE, 2024, 27 (06)
  • [14] Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
    Jian, Fanchong
    Wang, Jing
    Yisimayi, Ayijiang
    Song, Weiliang
    Xu, Yanli
    Chen, Xiaosu
    Niu, Xiao
    Yang, Sijie
    Yu, Yuanling
    Wang, Peng
    Sun, Haiyan
    Yu, Lingling
    Wang, Jing
    Wang, Yao
    An, Ran
    Wang, Wenjing
    Ma, Miaomiao
    Xiao, Tianhe
    Gu, Qingqing
    Shao, Fei
    Wang, Youchun
    Shen, Zhongyang
    Jin, Ronghua
    Cao, Yunlong
    NATURE, 2025, 637 (8047) : 921 - 929
  • [15] Increased faecal shedding in SARS-CoV-2 variants BA.2.86 and JN.1
    Wannigama, Dhammika Leshan
    Amarasiri, Mohan
    Phattharapornjaroen, Phatthranit
    Hurst, Cameron
    Modchang, Charin
    Chadsuthi, Sudarat
    Anupong, Suparinthon
    Miyanaga, Kazuhiko
    Cui, Longzhu
    Fernandez, Stefan
    Huang, Angkana
    Ounjai, Puey
    Singer, Andrew C.
    Ragupathi, Naveen Kumar Devanga
    Sano, Daisuke
    Furukawa, Takashi
    Sei, Kazunari
    Leelahavanichkul, Asada
    Kanjanabuch, Talerngsak
    Chatsuwan, Tanittha
    Higgins, Paul G.
    Nanbo, Asuka
    Kicic, Anthony
    Siow, Richard
    Trowsdale, Sam
    Hongsing, Parichart
    Khatib, Aisha
    Shibuya, Kenji
    Abe, Shuichi
    Ishikawa, Hitoshi
    LANCET INFECTIOUS DISEASES, 2024, 24 (06): : e348 - e350
  • [16] A recombinant protein vaccine induces protective immunity against SARS-CoV-2 JN.1 and XBB-lineage subvariants
    Yang, Jingyun
    Hong, Weiqi
    Shi, Huashan
    Wang, Zhenling
    He, Cai
    Lei, Hong
    Yan, Hong
    Alu, Aqu
    Ao, Danyi
    Chen, Zimin
    Zhou, Yanan
    Yang, Hao
    Yang, Yun
    Yu, Wenhai
    Tang, Cong
    Wang, Junbin
    Li, Bai
    Huang, Qing
    Hu, Hongbo
    Cheng, Wei
    Dong, Haohao
    Lei, Jian
    Chen, Lu
    Zhou, Xikun
    Yang, Li
    Wang, Wei
    Shen, Guobo
    Yang, Jinliang
    Zhao, Zhiwei
    Song, Xiangrong
    Sun, Qiangming
    Wang, Youchun
    Lu, Shuaiyao
    Li, Jiong
    Lu, Guangwen
    Li, Weimin
    Wei, Yuquan
    Wei, Xiawei
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2025, 10 (01)
  • [17] The rising SARS-CoV-2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
    Lu, Yishan
    Ao, Danyi
    He, Xuemei
    Wei, Xiawei
    MEDCOMM, 2024, 5 (08):
  • [18] Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
    Michael S. Piepenbrink
    Ahmed Magdy Khalil
    Ana Chang
    Ahmed Mostafa
    Madhubanti Basu
    Sanghita Sarkar
    Simran Panjwani
    Yaelyn H. Ha
    Yao Ma
    Chengjin Ye
    Qian Wang
    Todd J. Green
    James L. Kizziah
    Nathaniel B. Erdmann
    Paul A. Goepfert
    Lihong Liu
    David D. Ho
    Luis Martinez-Sobrido
    Mark R. Walter
    James J. Kobie
    npj Viruses, 2 (1):
  • [19] Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
    Park, Young-Jun
    Pinto, Dora
    Walls, Alexandra C.
    Liu, Zhuoming
    De Marco, Anna
    Benigni, Fabio
    Zatta, Fabrizia
    Silacci-Fregni, Chiara
    Bassi, Jessica
    Sprouse, Kaitlin R.
    Addetia, Amin
    Bowen, John E.
    Stewart, Cameron
    Giurdanella, Martina
    Saliba, Christian
    Guarino, Barbara
    Schmid, Michael A.
    Franko, Nicholas M.
    Logue, Jennifer K.
    Dang, Ha V.
    Hauser, Kevin
    di Iulio, Julia
    Rivera, William
    Schnell, Gretja
    Rajesh, Anushka
    Zhou, Jiayi
    Farhat, Nisar
    Kaiser, Hannah
    Montiel-Ruiz, Martin
    Noack, Julia
    Lempp, Florian A.
    Janer, Javier
    Abdelnabi, Rana
    Maes, Piet
    Ferrari, Paolo
    Ceschi, Alessandro
    Giannini, Olivier
    De Melo, Guilherme Dias
    Kergoat, Lauriane
    Bourhy, Herve
    Neyts, Johan
    Soriaga, Leah
    Purcell, Lisa A.
    Snell, Gyorgy
    Whelan, Sean P. J.
    Lanzavecchia, Antonio
    Virgin, Herbert W.
    Piccoli, Luca
    Chu, Helen Y.
    Pizzuto, Matteo Samuele
    SCIENCE, 2022, 378 (6620) : 619 - +
  • [20] Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
    Miah Roney
    Mohd Fadhlizil Fasihi Mohd Aluwi
    Bulletin of the National Research Centre, 48 (1)
12345